IRCT2015090723927N1已完成2 期
Sertraline effectiveness in prevention of depression, fatigue reduction and QOL improvement in MS patients.
Vice chancellor for research,Tabriz university of medical science.0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 79 years 至 34 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •Age 15-60;Primary education Exclusion;
- •Other Organic illnesses:Other mental disorder;Smoking and substance induce or alcohol abuser.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A study in the effects of sertraline on depressive symptoms of patients with inoperable advanced pancreatic cancerInoperable advanced pancreatic cancerJPRN-UMIN000003383agoya University Hospital30
招募中
3 期
The effect of sertralin on the depression and of serum prolactin levels among PCOD patientsPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20090117001556N123Tehran University of Medical Sciences40
已完成
不适用
A study of efficacy and safety of sertraline for the treatment of major depressive disorder patients, who have benn unremitted or intolerant by paroxetine or fluvoxamineJPRN-UMIN000002654Hokkaido University Hospital, Department of Psychiatry140
已完成
2 期
Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart FailureDepressionHeart Failure, CongestiveChronic Heart FailureNCT00078286Duke University469
招募中
2 期
Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression levelIRCT20180425039418N4Zahedan University of Medical Sciences60